Clinical presentation and long-term outcome of 144 patients with microscopic polyangiitis in a monocentric German cohort
Standard
Clinical presentation and long-term outcome of 144 patients with microscopic polyangiitis in a monocentric German cohort. / Schirmer, Jan H; Wright, Marvin N; Vonthein, Reinhard; Herrmann, Kristine; Nölle, Bernhard; Both, Marcus; Henes, Frank O; Arlt, Andreas; Gross, Wolfgang L; Schinke, Susanne; Reinhold-Keller, Eva; Moosig, Frank; Holle, Julia U.
In: RHEUMATOLOGY, Vol. 55, No. 1, 01.2016, p. 71-9.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Clinical presentation and long-term outcome of 144 patients with microscopic polyangiitis in a monocentric German cohort
AU - Schirmer, Jan H
AU - Wright, Marvin N
AU - Vonthein, Reinhard
AU - Herrmann, Kristine
AU - Nölle, Bernhard
AU - Both, Marcus
AU - Henes, Frank O
AU - Arlt, Andreas
AU - Gross, Wolfgang L
AU - Schinke, Susanne
AU - Reinhold-Keller, Eva
AU - Moosig, Frank
AU - Holle, Julia U
N1 - © The Author 2015. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
PY - 2016/1
Y1 - 2016/1
N2 - OBJECTIVE: To evaluate the clinical presentation and long-term outcome of a vasculitis centre cohort of patients with microscopic polyangiitis (MPA) with respect to organ manifestations, treatment, chronic damage and mortality.METHODS: We performed a retrospective chart review at our vasculitis referral centre. MPA patients admitted between 1991 and 2013 classified by a modified European Medicines Agency algorithm were diagnosed and treated according to a standardized interdisciplinary approach.RESULTS: Comprehensive data from standardized interdisciplinary workups was available for 144 patients (median follow-up 72 months). The overall standardized mortality ratio was 1.40 (95% CI 0.91, 2.07; P = 0.13). We observed a higher mortality [hazard ratio (HR) 4.04 (95% CI 1.21, 13.45), P = 0.02] in 17 patients with MPA-associated fibrosing interstitial lung disease (ILD) and 56 patients with peripheral nervous system involvement [HR 5.26 (95% CI 1.10, 25.14), P = 0.04] at disease onset. One hundred and fifteen patients (79.9%) responded to the initial treatment. Sixty-one (42.3%) achieved complete remission and 54 (37.5%) achieved partial remission. Twenty (13.9%) showed a refractory disease course.CONCLUSION: MPA patients at our tertiary rheumatology referral centre seemed to have a less severe phenotype resulting in a less severe disease course and better outcome than reported in other cohorts. Fibrosing ILD was significantly associated with mortality in this cohort.
AB - OBJECTIVE: To evaluate the clinical presentation and long-term outcome of a vasculitis centre cohort of patients with microscopic polyangiitis (MPA) with respect to organ manifestations, treatment, chronic damage and mortality.METHODS: We performed a retrospective chart review at our vasculitis referral centre. MPA patients admitted between 1991 and 2013 classified by a modified European Medicines Agency algorithm were diagnosed and treated according to a standardized interdisciplinary approach.RESULTS: Comprehensive data from standardized interdisciplinary workups was available for 144 patients (median follow-up 72 months). The overall standardized mortality ratio was 1.40 (95% CI 0.91, 2.07; P = 0.13). We observed a higher mortality [hazard ratio (HR) 4.04 (95% CI 1.21, 13.45), P = 0.02] in 17 patients with MPA-associated fibrosing interstitial lung disease (ILD) and 56 patients with peripheral nervous system involvement [HR 5.26 (95% CI 1.10, 25.14), P = 0.04] at disease onset. One hundred and fifteen patients (79.9%) responded to the initial treatment. Sixty-one (42.3%) achieved complete remission and 54 (37.5%) achieved partial remission. Twenty (13.9%) showed a refractory disease course.CONCLUSION: MPA patients at our tertiary rheumatology referral centre seemed to have a less severe phenotype resulting in a less severe disease course and better outcome than reported in other cohorts. Fibrosing ILD was significantly associated with mortality in this cohort.
KW - Adolescent
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Disease Progression
KW - Female
KW - Follow-Up Studies
KW - Germany
KW - Glucocorticoids
KW - Humans
KW - Immunosuppressive Agents
KW - Incidence
KW - Male
KW - Microscopic Polyangiitis
KW - Middle Aged
KW - Remission Induction
KW - Retrospective Studies
KW - Survival Rate
KW - Time Factors
KW - Young Adult
KW - Journal Article
U2 - 10.1093/rheumatology/kev286
DO - 10.1093/rheumatology/kev286
M3 - SCORING: Journal article
C2 - 26297628
VL - 55
SP - 71
EP - 79
JO - RHEUMATOLOGY
JF - RHEUMATOLOGY
SN - 1462-0324
IS - 1
ER -